Rafferty Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Sell |
37,207
-14,650
| -28% | -$746K | 0.01% | 617 |
|
|
2025
Q1 | $2.34M | Buy |
51,857
+6,697
| +15% | +$302K | 0.01% | 534 |
|
|
2024
Q4 | $1.87M | Sell |
45,160
-40,297
| -47% | -$1.67M | 0.01% | 665 |
|
|
2024
Q3 | $3.33M | Buy |
85,457
+16,599
| +24% | +$647K | 0.01% | 505 |
|
|
2024
Q2 | $2.35M | Sell |
68,858
-197,404
| -74% | -$6.75M | 0.01% | 602 |
|
|
2024
Q1 | $6.69M | Buy |
266,262
+135,916
| +104% | +$3.41M | 0.03% | 392 |
|
|
2023
Q4 | $3.85M | Sell |
130,346
-6,859
| -5% | -$202K | 0.02% | 503 |
|
|
2023
Q3 | $4.34M | Buy |
137,205
+21,312
| +18% | +$673K | 0.03% | 421 |
|
|
2023
Q2 | $3M | Buy |
115,893
+29,732
| +35% | +$769K | 0.02% | 529 |
|
|
2023
Q1 | $2.07M | Sell |
86,161
-60,083
| -41% | -$1.44M | 0.01% | 603 |
|
|
2022
Q4 | $2.85M | Buy |
146,244
+87,697
| +150% | +$1.71M | 0.02% | 496 |
|
|
2022
Q3 | $1.23M | Buy |
+58,547
| New | +$1.23M | 0.01% | 616 |
|